Contact
searchSearch
HMP Global

Infection Topic Center

Featured Article

FDA Alert
News
FDA Approves New Oral Treatment to Prevent C.Diff Recurrence
05/01/2023
Priyam Vora
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug...
05/01/2023
Gastroenterology
light bulb+idea+thinking+poll
Poll
Gastro Issues Post-COVID-19
01/10/2023
Regardless of ICU status, nearly 1 in 5 US patients hospitalized with COVID-19 have experienced gastrointestinal symptoms in some form, a multicenter cohort study confirmed. Which of the following issues have you seen among your patients who...
Regardless of ICU status, nearly 1 in 5 US patients hospitalized with COVID-19 have experienced gastrointestinal symptoms in some form, a multicenter cohort study confirmed. Which of the following issues have you seen among your patients who...
Regardless of ICU status, nearly...
01/10/2023
Gastroenterology
News
Gastrointestinal Symptoms Common in Patients Hospitalized With COVID-19
08/08/2022
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among...
08/08/2022
Gastroenterology
Lab
Conference Coverage
Nobel Laureate Barry Marshall, MD, Headlines DDW Session on H pylori
05/22/2021
In fewer than 40 years, Helicobacter pylori has advanced from a disputed factor in causation of gastric ulcers to a bacterium that shows increasing resistance to antibiotic therapies.
In fewer than 40 years, Helicobacter pylori has advanced from a disputed factor in causation of gastric ulcers to a bacterium that shows increasing resistance to antibiotic therapies.
In fewer than 40 years,...
05/22/2021
Gastroenterology
News
ACG Releases New Guideline on C Diff
05/21/2021
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of...
05/21/2021
Gastroenterology
News
Researchers Study Potential Risks of FMT
04/21/2021
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation...
04/21/2021
Gastroenterology
News
GI Infections May Lead to Microscopic Colitis
04/21/2021
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to...
04/21/2021
Gastroenterology
News
Severe Course of COVID-19 May Be Associated With Poor GI Health
01/13/2021
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing...
01/13/2021
Gastroenterology
GI Symptoms Predict Worse Outcomes in COVID-19
Conference Coverage
GI Symptoms Predict Worse Outcomes in COVID-19
10/29/2020
In the largest study to date on the significance of gastrointestinal symptoms associated with COVID-19 infection in the United States, researchers found that patients with nausea, diarrhea, and other gastric symptoms were more likely to need...
In the largest study to date on the significance of gastrointestinal symptoms associated with COVID-19 infection in the United States, researchers found that patients with nausea, diarrhea, and other gastric symptoms were more likely to need...
In the largest study to date on...
10/29/2020
Gastroenterology

News

FDA Alert
News
FDA Approves New Oral Treatment to Prevent C.Diff Recurrence
05/01/2023
Priyam Vora
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug...
05/01/2023
Gastroenterology
News
Gastrointestinal Symptoms Common in Patients Hospitalized With COVID-19
08/08/2022
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among...
08/08/2022
Gastroenterology
News
ACG Releases New Guideline on C Diff
05/21/2021
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of...
05/21/2021
Gastroenterology
News
Researchers Study Potential Risks of FMT
04/21/2021
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation...
04/21/2021
Gastroenterology
News
GI Infections May Lead to Microscopic Colitis
04/21/2021
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to...
04/21/2021
Gastroenterology
News
Severe Course of COVID-19 May Be Associated With Poor GI Health
01/13/2021
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing...
01/13/2021
Gastroenterology
Research Highlights
Incidence of Hepatocellular Carcinoma in MASLD Patients Quantified in Large Meta-Analysis
09/15/2025
Rebecca Mashaw
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight...
09/15/2025
Gastroenterology
FDA Alert
Obeticholic Acid Withdrawn From US Market for PBC; FDA Puts Clinical Trials on Hold
09/15/2025
Rebecca Mashaw
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will...
09/15/2025
Gastroenterology
Research Highlights
Analysis Challenges NordICC Trial Conclusions on CRC Screening and Mortality
09/05/2025
Rebecca Mashaw
The 10-year results from the NordICC study may underestimate the mortality benefits of screening colonoscopy due to inadequate follow-up time.
The 10-year results from the NordICC study may underestimate the mortality benefits of screening colonoscopy due to inadequate follow-up time.
The 10-year results from the...
09/05/2025
Gastroenterology
Research Highlights
Cumulative Social Risk Linked to Poorer Survival in Stage III Colorectal Cancer
09/05/2025
Rebecca Mashaw
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found...
09/05/2025
Gastroenterology
Research Highlights
Fatty Pancreas Disease Linked to Elevated Risk of Pancreatic Cancer
09/04/2025
Jessica Garlewicz
The key takeaway for clinicians is the importance of recognizing fatty pancreas disease as more than an incidental imaging finding.
The key takeaway for clinicians is the importance of recognizing fatty pancreas disease as more than an incidental imaging finding.
The key takeaway for clinicians...
09/04/2025
Gastroenterology
News
Hypertension Linked to Liver Disease Progression and Adverse Outcomes in MASLD
09/04/2025
Jessica Garlewicz
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective...
09/04/2025
Gastroenterology
News
GLP-1 Receptor Agonists Linked to Lower Risk of Peptic Ulcer Disease in Patients with T2DM
09/04/2025
Jessica Garlewicz
GLP-1 RAs may offer additional protection against gastrointestinal complications among patients with type 2 diabetes mellitus.
GLP-1 RAs may offer additional protection against gastrointestinal complications among patients with type 2 diabetes mellitus.
GLP-1 RAs may offer additional...
09/04/2025
Gastroenterology
FDA alert
FDA Alert
FDA Approves Semaglutide for MASH With Advanced Fibrosis
08/21/2025
Rebecca Mashaw
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option...
08/21/2025
Gastroenterology
News
Racial Disparities Persist in Colorectal Cancer Outcomes
08/12/2025
Rebecca Mashaw
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite significant advances in...
08/12/2025
Gastroenterology
News
Over 20 Years of Colorectal Cancer Disparities Reveal Racial and Regional Gaps in US Mortality
08/08/2025
Riya Gandhi, MA
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.
Despite national declines in...
08/08/2025
Gastroenterology

Interactive

light bulb+idea+thinking+poll
Poll
Gastro Issues Post-COVID-19
01/10/2023
Regardless of ICU status, nearly 1 in 5 US patients hospitalized with COVID-19 have experienced gastrointestinal symptoms in some form, a multicenter cohort study confirmed. Which of the following issues have you seen among your patients who...
Regardless of ICU status, nearly 1 in 5 US patients hospitalized with COVID-19 have experienced gastrointestinal symptoms in some form, a multicenter cohort study confirmed. Which of the following issues have you seen among your patients who...
Regardless of ICU status, nearly...
01/10/2023
Gastroenterology
Quiz
Diagnostic Complexity in Refractory GERD
08/07/2025
Rebecca Mashaw
What did researchers find in a recent study of patients with GERD and persistent reflux symptoms despite PPI therapy? Take our quick quiz to find out!
What did researchers find in a recent study of patients with GERD and persistent reflux symptoms despite PPI therapy? Take our quick quiz to find out!
What did researchers find in a...
08/07/2025
Gastroenterology
Quiz
Terminal Ileal Resection and CRC Risk
08/07/2025
Rebecca Mashaw
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in...
08/07/2025
Gastroenterology
Quiz
DGBIs and GERD
08/07/2025
Rebecca Mashaw
Is there any association between esophageal disorders of gut-brain interaction and refractory reflux symptoms? Test your knowledge with our quick quiz!
Is there any association between esophageal disorders of gut-brain interaction and refractory reflux symptoms? Test your knowledge with our quick quiz!
Is there any association between...
08/07/2025
Gastroenterology
News
Prevalence of Overlapping Esophageal DGBIs and GERD in Patients With Refractory Reflux
08/01/2025
Rebecca Mashaw
A prospective study reveals that more than 70% of patients with proven gastroesophageal reflux disease and refractory symptoms also exhibit features of esophageal disorders of gut-brain interaction.
A prospective study reveals that more than 70% of patients with proven gastroesophageal reflux disease and refractory symptoms also exhibit features of esophageal disorders of gut-brain interaction.
A prospective study reveals that...
08/01/2025
Gastroenterology
Quiz
How Does Stool-Based CRC Surveillance Compare to Colonoscopy?
07/21/2025
Rebecca Mashaw
07/21/2025
Gastroenterology
Quiz
How Does CRC Affect Sexual Health in Women Over 40?
07/21/2025
Rebecca Mashaw
07/21/2025
Gastroenterology
Quiz
How Does CRC Affect Sexual Health in Women Under 40?
07/21/2025
Rebecca Mashaw
07/21/2025
Gastroenterology
Quiz
What Improves FIT Return Rates?
07/18/2025
The TEMPO trial investigated techniques to improve return rates for fecal immunochemical tests for colorectal cancer. Find out what worked best by taking our quick quiz!
The TEMPO trial investigated techniques to improve return rates for fecal immunochemical tests for colorectal cancer. Find out what worked best by taking our quick quiz!
The TEMPO trial investigated...
07/18/2025
Gastroenterology
Quiz
Social Determinants of Health and MASLD/MASH
07/18/2025
Rebecca Mashaw
Research has shown that several social determinants of health (SDOH) are associated with the prevalence of metabolic-associated steatotic liver disease. What has been identified as the most consistent associated SDOH?
Research has shown that several social determinants of health (SDOH) are associated with the prevalence of metabolic-associated steatotic liver disease. What has been identified as the most consistent associated SDOH?
Research has shown that several...
07/18/2025
Gastroenterology
Quiz
MASLD in 2050
07/18/2025
Rebecca Mashaw
The prevalence of metabolic-associated steatotic liver disease (MASLD) is increasing. What will it be in the future? Take our quiz to find out.
The prevalence of metabolic-associated steatotic liver disease (MASLD) is increasing. What will it be in the future? Take our quiz to find out.
The prevalence of...
07/18/2025
Gastroenterology

Sign up for our e-Newsletters

Gastroenterology Newsletter

News

FDA Alert
News
FDA Approves New Oral Treatment to Prevent C.Diff Recurrence
05/01/2023
Priyam Vora
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug...
05/01/2023
Gastroenterology
News
Gastrointestinal Symptoms Common in Patients Hospitalized With COVID-19
08/08/2022
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among...
08/08/2022
Gastroenterology
News
ACG Releases New Guideline on C Diff
05/21/2021
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of...
05/21/2021
Gastroenterology
News
Researchers Study Potential Risks of FMT
04/21/2021
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation...
04/21/2021
Gastroenterology
News
GI Infections May Lead to Microscopic Colitis
04/21/2021
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to...
04/21/2021
Gastroenterology
News
Severe Course of COVID-19 May Be Associated With Poor GI Health
01/13/2021
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing...
01/13/2021
Gastroenterology
Research Highlights
Incidence of Hepatocellular Carcinoma in MASLD Patients Quantified in Large Meta-Analysis
09/15/2025
Rebecca Mashaw
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight...
09/15/2025
Gastroenterology
FDA Alert
Obeticholic Acid Withdrawn From US Market for PBC; FDA Puts Clinical Trials on Hold
09/15/2025
Rebecca Mashaw
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will...
09/15/2025
Gastroenterology
Research Highlights
Analysis Challenges NordICC Trial Conclusions on CRC Screening and Mortality
09/05/2025
Rebecca Mashaw
The 10-year results from the NordICC study may underestimate the mortality benefits of screening colonoscopy due to inadequate follow-up time.
The 10-year results from the NordICC study may underestimate the mortality benefits of screening colonoscopy due to inadequate follow-up time.
The 10-year results from the...
09/05/2025
Gastroenterology
Research Highlights
Cumulative Social Risk Linked to Poorer Survival in Stage III Colorectal Cancer
09/05/2025
Rebecca Mashaw
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found...
09/05/2025
Gastroenterology
Research Highlights
Fatty Pancreas Disease Linked to Elevated Risk of Pancreatic Cancer
09/04/2025
Jessica Garlewicz
The key takeaway for clinicians is the importance of recognizing fatty pancreas disease as more than an incidental imaging finding.
The key takeaway for clinicians is the importance of recognizing fatty pancreas disease as more than an incidental imaging finding.
The key takeaway for clinicians...
09/04/2025
Gastroenterology
News
Hypertension Linked to Liver Disease Progression and Adverse Outcomes in MASLD
09/04/2025
Jessica Garlewicz
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective...
09/04/2025
Gastroenterology
News
GLP-1 Receptor Agonists Linked to Lower Risk of Peptic Ulcer Disease in Patients with T2DM
09/04/2025
Jessica Garlewicz
GLP-1 RAs may offer additional protection against gastrointestinal complications among patients with type 2 diabetes mellitus.
GLP-1 RAs may offer additional protection against gastrointestinal complications among patients with type 2 diabetes mellitus.
GLP-1 RAs may offer additional...
09/04/2025
Gastroenterology
FDA alert
FDA Alert
FDA Approves Semaglutide for MASH With Advanced Fibrosis
08/21/2025
Rebecca Mashaw
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option...
08/21/2025
Gastroenterology
News
Racial Disparities Persist in Colorectal Cancer Outcomes
08/12/2025
Rebecca Mashaw
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite significant advances in...
08/12/2025
Gastroenterology
News
Over 20 Years of Colorectal Cancer Disparities Reveal Racial and Regional Gaps in US Mortality
08/08/2025
Riya Gandhi, MA
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.
Despite national declines in...
08/08/2025
Gastroenterology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use